Melanocyte

✅ Treats skin conditions
✅ Manages vitiligo
✅ Psoralen therapy
✅ Controls eczema
✅ Reduces depigmentation

Melanocyl contains Methoxsalen.

Product Overview

Melanocyl is a pharmaceutical preparation containing Methoxsalen as its active component. This medication is principally indicated for dermatological conditions including vitiligo and psoriasis. Its mechanism of action involves enhancing skin photosensitivity to ultraviolet radiation, thereby facilitating therapeutic effects in specific cutaneous disorders. Available in both systemic and topical formulations, Melanocyl provides versatile treatment modalities. Strict adherence to medical supervision is imperative to ensure therapeutic efficacy and safety.

Therapeutic Applications

Melanocyl is clinically employed in the management of various dermatopathies, notably vitiligo (characterized by depigmented cutaneous patches) and psoriasis (a chronic immune-mediated disorder manifesting as erythematous, scaly plaques). The drug potentiates phototherapeutic effects by augmenting cutaneous photosensitivity, thereby promoting repigmentation in vitiligo and mitigating psoriatic inflammation and hyperproliferation.

Administration Guidelines

Melanocyl is formulated for both oral ingestion and topical application. Oral administration should be accompanied by food or dairy products to minimize gastrointestinal irritation. Topical preparations require direct application to affected dermatological regions. Strict compliance with prescribing physician’s instructions is mandatory. Post-administration photoprotection is essential to prevent phototoxic reactions.

Pharmacological Mechanism

The active constituent Methoxsalen functions as a photosensitizing agent, primarily targeting UVA spectrum radiation. Following drug administration and subsequent UVA exposure, photochemical interactions induce cellular modifications in epidermal tissue. These biochemical alterations facilitate repigmentation processes in vitiligo and modulate pathological keratinocyte proliferation in psoriasis.

Dosage Protocol

Melanocyl dosing regimens are individualized based on clinical presentation and therapeutic response. Standard oral dosing ranges from 10-60 mg, administered 90-120 minutes preceding UVA exposure. Topical application protocols are determined by the treating physician. Strict adherence to prescribed dosing schedules is paramount for optimal therapeutic outcomes.

Therapeutic Advantages

Melanocyl demonstrates significant clinical benefits in dermatological therapeutics, including:
– Restoration of cutaneous pigmentation in vitiligo
– Reduction of psoriatic inflammation and desquamation
– Enhancement of phototherapy efficacy
– Improvement in overall cutaneous integrity and aesthetic appearance

Adverse Effects

Common adverse reactions may include:
– Gastrointestinal discomfort
– Cephalalgia
– Vertigo
– Cutaneous irritation
– Photosensitivity reactions
Severe phototoxic responses or hypersensitivity manifestations require immediate medical attention.

Precautions and Contraindications

Prior to Melanocyl administration, comprehensive medical evaluation is mandatory, particularly for patients with hepatic/renal impairment or concurrent pharmacotherapy. Stringent photoprotective measures must be observed post-administration. Pregnancy and lactation constitute special populations requiring physician consultation before therapy initiation.

Storage Conditions

Maintain Melanocyl preparations at controlled room temperature (15-30°C) in moisture-resistant, light-protected containers. Ensure secure storage away from pediatric and animal access. Discard expired or compromised pharmaceutical products appropriately.

Medical Disclaimer

The provided information is intended for educational purposes and represents current medical knowledge at time of publication. This content does not substitute professional medical advice, diagnosis, or treatment. Consult qualified healthcare providers for personalized medical guidance. The information presented may not encompass all potential adverse effects, drug interactions, or contraindications. This resource aims to supplement, not replace, the physician-patient relationship. Always seek the advice of your physician regarding any medical condition or treatment.

Strength

10 mg

Quantity

40 Tablet/s, 80 Tablet/s, 120 Tablet/s, 240 Tablet/s

Reviews

There are no reviews yet

Add a review
Melanocyte Melanocyte
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot